Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: Implications for transplantation

Journal of Experimental Medicine

Volumn 207, Issue 11, 2010, Pages 2355-2367

  Araki, Koichi ^a   Gangappa, Shivaprakash ^a,b   Dillehay, Dirck L ^a   Rouse, Barry T ^c   Larsen, Christian P ^a,b   Ahmed, Rafi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TACROLIMUS; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSPLANTATION; VIRUS INFECTION;

ANIMALS; CALCINEURIN; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, KNOCKOUT; ORGAN TRANSPLANTATION; T-LYMPHOCYTES; TACROLIMUS; TRANSPLANTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78149306056     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100124     Document Type: Article

References (40)

1. Ahmed, R., A. Salmi, L.D. Butler, J.M. Chiller, and M.B. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521-540. doi:10.1084/jem.160.2. 521
2. Araki, K., A.P. Turner, V.O. Shaffer, S. Gangappa, S.A. Keller, M.F. Bachmann, C.P. Larsen, and R. Ahmed. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature. 460:108-112. doi:10.1038/nature08155
3. Barber, D.L., E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, A.H. Sharpe, G.J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439:682-687. doi:10.1038/ nature04444
4. Borrow, P., and M.B.A. Oldstone. 1997. Lymphocytic choriomeningitis virus. In Viral pathogenesis. N. Nathanson, editor. Lippincott-Raven, Philadelphia. 593-627.
5. Buchmeier, M.J., J.C. de la Torre, and C.J. Peters. 2007. Arenaviridae: The viruses and their replication. In Fields Virology. Vol. 2. D.M. Knipe and P.M. Howley, editors. Lippincott Williams & Wilkins, Philadelphia. 1791-1827.
6. Centers for Disease Control and Prevention (CDC). 2005. Lymphocytic choriomeningitis virus infection in organ transplant recipients - Massachusetts, Rhode Island, 2005. MMWR Morb. Mortal. Wkly. Rep. 54:537-539.
7. Centers for Disease Control and Prevention (CDC). 2008. Brief report: Lymphocytic choriomeningitis virus transmitted through solid organ transplantation - Massachusetts, 2008. MMWR Morb. Mortal. Wkly. Rep. 57:799-801.
8. Chisholm, P.M., M.T. Drayson, J.H. Cox, and W.L. Ford. 1985. The effects of cyclosporin on lymphocyte activation in a systemic graft-vs.-host reaction. Eur. J. Immunol. 15:1054-1059. doi:10.1002/eji.1830151018
9. Day, C.L., D.E. Kaufmann, P. Kiepiela, J.A. Brown, E.S. Moodley, S. Reddy, E.W. Mackey, J.D. Miller, A.J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 443:350-354. doi:10.1038/nature05115
10. Fischer, S.A., M.B. Graham, M.J. Kuehnert, C.N. Kotton, A. Srinivasan, F.M. Marty, J.A. Comer, J. Guarner, C.D. Paddock, D.L. DeMeo, et al; LCMV in Transplant Recipients Investigation Team. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354:2235-2249. doi:10.1056/NEJMoa053240
11. Fishman, J.A. 2007. Infection in solid-organ transplant recipients. N. Engl. J. Med. 357:2601-2614. doi:10.1056/NEJMra064928
12. Fishman, J.A., and R.H. Rubin. 1998. Infection in organ-transplant recipients. N. Engl. J. Med. 338:1741-1751. doi:10.1056/NEJM199806113382407
13. Giraudo, E., M. Arese, C. Toniatti, M. Strasly, L. Primo, A. Mantovani, G. Ciliberto, and F. Bussolini. 1996. IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells. J. Immunol. 157:2618-2623.
14. Grayson, J.M., L.E. Harrington, J.G. Lanier, E.J. Wherry, and R. Ahmed. 2002. Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo. J. Immunol. 169:3760-3770.
15. + T cells. J. Exp. Med. 186:1407-1418. doi:10.1084/jem.186.9.1407
16. Joshi, N.S., W. Cui, A. Chandele, H.K. Lee, D.R. Urso, J. Hagman, L. Gapin, and S.M. Kaech. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity. 27:281-295. doi:10.1016/j.immuni.2007.07.010
17. Kolumam, G.A., S. Thomas, L.J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202:637-650. doi:10.1084/jem.20050821
18. Kotton, C.N. 2007. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 44:857-866. doi:10.1086/511859
19. Kroczek, R.A., C.D. Black, J. Barbet, and E.M. Shevach. 1987. Mechanism of action of cyclosporin A in vivo. I. Cyclosporin A fails to inhibit T lymphocyte activation in response to alloantigens. J. Immunol. 139:3597-3603.
20. Kumar, D., and A. Humar. 2005. Emerging viral infections in transplant recipients. Curr. Opin. Infect. Dis. 18:337-341. doi:10.1097/01.qco.0000172697. 44784.ff
21. Möller, B., and P.M. Villiger. 2006. Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases. Springer Semin. Immunopathol. 27:391-408. doi:10.1007/s0028100600129
22. Murali-Krishna, K., and R. Ahmed. 2000. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165:1733-1737.
23. Murali-Krishna, K., J.D. Altman, M. Suresh, D.J. Sourdive, A.J. Zajac, J.D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:177-187. doi:10.1016/S10747613(00)804707
24. Oestreich, K.J., H. Yoon, R. Ahmed, and J.M. Boss. 2008. NFATc1 regulates PD-1 expression upon T cell activation. J. Immunol. 181:4832-4839.
25. Oldstone, M.B., J. Holmstoen, and R.M. Welsh Jr. 1977. Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus. J. Cell. Physiol. 91:459-472. doi:10.1002/jcp.1040910316
26. Palacios, G., J. Druce, L. Du, T. Tran, C. Birch, T. Briese, S. Conlan, P.L. Quan, J. Hui, J. Marshall, et al. 2008. A new arenavirus in a cluster of fatal transplant-associated diseases. N. Engl. J. Med. 358:991-998. doi:10.1056/NEJMoa073785
27. Pearce, E.L., M.C. Walsh, P.J. Cejas, G.M. Harms, H. Shen, L.S. Wang, R.G. Jones, and Y. Choi. 2009. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 460:103-107. doi:10.1038/nature08097
28. Peters, C.J. 2006. Lymphocytic choriomeningitis virus - an old enemy up to new tricks. N. Engl. J. Med. 354:2208-2211. doi:10.1056/NEJMp068021
29. + T cell survival in HIV infection. J. Exp. Med. 203:2281-2292. doi:10.1084/jem.20061496
30. Radziewicz, H., C.C. Ibegbu, M.L. Fernandez, K.A. Workowski, K. Obideen, M. Wehbi, H.L. Hanson, J.P. Steinberg, D. Masopust, E.J. Wherry, et al. 2007. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81:2545-2553. doi:10.1128/JVI.0202106
31. Sarkar, S., V. Kalia, W.N. Haining, B.T. Konieczny, S. Subramaniam, and R. Ahmed. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205:625-640. doi:10.1084/jem.20071641
32. Schubert, D., B. Maier, L. Morawietz, V. Krenn, and T. Kamradt. 2004. Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J. Immunol. 172:4503-4509.
33. Singh, N. 2003. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients. Lancet Infect. Dis. 3:156-161. doi:10.1016/S14733099(03)005462
34. Trautmann, L., L. Janbazian, N. Chomont, E.A. Said, S. Gimmig, B. Bessette, M.R. Boulassel, E. Delwart, H. Sepulveda, R.S. Balderas, et al. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12:1198-1202. doi:10.1038/nm1482
35. Voehringer, D., C. Blaser, P. Brawand, D.H. Raulet, T. Hanke, and H. Pircher. 2001. Viral infections induce abundant numbers of senescent CD8 T cells. J. Immunol. 167:4838-4843.
36. Wherry, E.J., J.N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911-4927. doi:10.1128/JVI.77.8.49114927.2003
37. Williams, M.A., A.J. Tyznik, and M.J. Bevan. 2006. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature. 441:890-893. doi:10.1038/nature04790
38. Wu, Y., M. Borde, V. Heissmeyer, M. Feuerer, A.D. Lapan, J.C. Stroud, D.L. Bates, L. Guo, A. Han, S.F. Ziegler, et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 126:375-387. doi:10.1016/j.cell.2006.05.042
39. Wullschleger, S., R. Loewith, and M.N. Hall. 2006. TOR signaling in growth and metabolism. Cell. 124:471-484. doi:10.1016/j.cell.2006.01.016
40. Zajac, A.J., J.N. Blattman, K. Murali-Krishna, D.J. Sourdive, M. Suresh, J.D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213. doi:10.1084/jem.188.12.2205